Literature DB >> 33553210

Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales.

Rémy A Bonnin1,2,3, Agnès B Jousset1,2,3,4, Cécile Emeraud1,2,3,4, Saoussen Oueslati1,3, Laurent Dortet1,2,3,4, Thierry Naas1,2,3,4.   

Abstract

Gram-negative bacteria, especially Enterobacterales, have emerged as major players in antimicrobial resistance worldwide. Resistance may affect all major classes of anti-gram-negative agents, becoming multidrug resistant or even pan-drug resistant. Currently, β-lactamase-mediated resistance does not spare even the most powerful β-lactams (carbapenems), whose activity is challenged by carbapenemases. The dissemination of carbapenemases-encoding genes among Enterobacterales is a matter of concern, given the importance of carbapenems to treat nosocomial infections. Based on their amino acid sequences, carbapenemases are grouped into three major classes. Classes A and D use an active-site serine to catalyze hydrolysis, while class B (MBLs) require one or two zinc ions for their activity. The most important and clinically relevant carbapenemases are KPC, IMP/VIM/NDM, and OXA-48. However, several carbapenemases belonging to the different classes are less frequently detected. They correspond to class A (SME-, Nmc-A/IMI-, SFC-, GES-, BIC-like…), to class B (GIM, TMB, LMB…), class C (CMY-10 and ACT-28), and to class D (OXA-372). This review will address the genetic diversity, biochemical properties, and detection methods of minor acquired carbapenemases in Enterobacterales.
Copyright © 2021 Bonnin, Jousset, Emeraud, Oueslati, Dortet and Naas.

Entities:  

Keywords:  CHDL; antibiotic resistance; carbapenem; detection; insertion sequence; transposon

Year:  2021        PMID: 33553210      PMCID: PMC7855592          DOI: 10.3389/fmed.2020.616490

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  196 in total

1.  Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 2.  Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.

Authors:  Ilias Karaiskos; Irene Galani; Maria Souli; Helen Giamarellou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-01-10       Impact factor: 4.481

Review 3.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

4.  Spread of Klebsiella pneumoniae ST45 Producing GES-5 Carbapenemase or GES-1 Extended-Spectrum β-Lactamase in Newborns and Infants.

Authors:  E Literacka; R Izdebski; P Urbanowicz; D Żabicka; J Klepacka; I Sowa-Sierant; I Żak; A Garus-Jakubowska; W Hryniewicz; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

5.  Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria.

Authors:  Delphine Girlich; Sandrine Bernabeu; Nicolas Fortineau; Laurent Dortet; Thierry Naas
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-09       Impact factor: 2.803

6.  Tripoli metallo-β-lactamase-1 (TMB-1)-producing Acinetobacter spp. with decreased resistance to imipenem in Japan.

Authors:  Shizuo Kayama; Norifumi Shigemoto; Wataru Shimizu; Ryuichi Kuwahara; Mitsuyasu Ikeda; Kouji Ikebe; Kikuyo Maeda; Junzo Hisatsune; Hiroki Ohge; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

7.  Enterobacter sp. N18-03635 harbouring blaFRI-6 class A carbapenemase, Canada.

Authors:  David A Boyd; Brigitte Lefebvre; Laura F Mataseje; Simon Gagnon; Michel Roger; Patrice Savard; Jean Longtin; Michael R Mulvey
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

Review 8.  New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

9.  Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany.

Authors:  Andreas F Wendel; Martin Kaase; Ingo B Autenrieth; Silke Peter; Philipp Oberhettinger; Heime Rieber; Klaus Pfeffer; Colin R MacKenzie; Matthias Willmann
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

10.  Genetic and biochemical characterization of GES-16, a new GES-type β-lactamase with carbapenemase activity in Serratia marcescens.

Authors:  Ana Paula Streling; Paula P Barbosa; Marcelo F Marcondes; Adriana G Nicoletti; Renata C Picão; Elisa C Pinto; Elizabeth A Marques; Vitor Oliveira; Ana C Gales
Journal:  Diagn Microbiol Infect Dis       Date:  2018-05-12       Impact factor: 2.803

View more
  2 in total

Review 1.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

2.  Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice.

Authors:  Zhijie Zhang; Dayan Wang; Yahui Li; Yong Liu; Xiaosong Qin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-21       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.